COUR vs ABUS
Comparison between Coursera Inc (COUR, Company) and Arbutus Biopharma Corp (ABUS, Company).
COUR is from the Consumer Defensive sector, while ABUS is from the Healthcare sector.
5-Year PerformanceABUS has outperformed COUR, delivering a return of +7.8% compared to -34.0%
COUR vs ABUS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
COUR vs ABUS - Historical Returns
Returns include dividend reinvestment.
COUR vs ABUS - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | COUR | ABUS |
|---|---|---|
| 2026 | -24.79% | -5.24% |
| 2025 | -13.21% | +46.20% |
| 2024 | -55.94% | +26.25% |
| 2023 | +56.84% | +12.11% |
| 2022 | -53.68% | -41.46% |
| 2021 | -45.69% | +6.87% |
| 2020 | N/A | +20.75% |
| 2019 | N/A | -30.50% |
| 2018 | N/A | -29.72% |
| 2017 | N/A | +102.00% |
| 2016 | N/A | -45.80% |
| 2015 | N/A | -57.62% |
COUR vs ABUS Drawdown Comparison
The maximum drawdown for COUR was -91.22%, occurring on May 14, 2026. This drawdown has not yet recovered.
The maximum drawdown for ABUS was -92.96%, occurring on Oct 9, 2019. This drawdown has not yet recovered.
The current COUR drawdown is -90.82%. The current ABUS drawdown is -63.40%.
| Rank | COUR | ABUS |
|---|---|---|
| #1 | -91.22% Apr 7, 2021 - May 14, 2026 | -92.96% Aug 2, 2018 - Oct 9, 2019 |
| #2 | N/A | -76.67% Aug 3, 2015 - Jul 11, 2018 |
| #3 | N/A | -8.12% Jul 13, 2018 - Aug 1, 2018 |
Correlation
Correlation between COUR and ABUS is -0.20 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks